This Article  • PDF of this Correction  • Original article  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Depression  • Schizophrenia  • Alert me on articles by topic  Social Bookmarking   What's this?

Arch Gen Psychiatry. 1998;55:1052.

In the article titled "Depressive Signs and Symptoms in Schizophrenia: A Prospective Blinded Trial of Olanzapine and Haloperidol," published in the March 1998 issue of the ARCHIVES (1998;55:250-258), an error appeared in Figure 2 on page 254. The bars for olanzapine and haloperidol should have been separated, the lighter bar representing haloperidol-associated change, and the darker bar, olanzapine-associated change. Figure 2 is reprinted correctly here.

View larger version (55K): [in this window] [in a new window] Figure 2. The individual Montgomery-Asberg Depression Rating Scale (MADRS) item contributions to the total score change. Those with an asterisk represent significant between-treatment differences (items 1-4 and 7), which all favored olanzapine. Asterisk indicates P<.05, F test of treatment effect using analysis of variance.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?